GlassScriptPhysician profile
Madeline Jenney
NPI 1407397987
$8,118.65
in general payments reported to CMS, 2019-2025
42 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,347 · 2022: $2,225 · 2023: $1,260 · 2024: $1,842 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,422 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,422.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,431.12 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $981.16 | 2023-2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $841.62 | 2021-2025 | Urgent PC Neuromodulation System, Eclipse, Endosheath Technology |
| Pfizer INC. | $530.36 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $323.13 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $312.60 | 2021-2024 | Myrbetriq, Veozah |
| Medtronic, INC. | $298.70 | 2021-2025 | Interstim, Altaviva |
| Janssen Biotech, INC. | $286.32 | 2021-2025 | Erleada, Akeega, Balversa |
| Antares Pharma, INC. | $267.88 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Srs Medical Systems, INC. | $247.82 | 2021-2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Urogen Pharma, INC. | $241.51 | 2021-2025 | Jelmyto |
| Myovant Sciences INC. | $222.04 | 2021-2022 | |
| Valencia Technologies Corporation | $205.40 | 2025 | Ecoin Device Kit |
| Abbvie INC. | $202.01 | 2021-2025 | |
| Urovant Sciences INC | $190.99 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $159.67 | 2022-2025 | Axonics, Rezum Generator |
| Coloplast Corp | $158.81 | 2023-2024 | Speedicath, Restorelle |
| Tolmar Pharmaceuticals, INC. | $129.84 | 2022 | |
| Tolmar, INC. | $94.41 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $93.31 | 2022-2025 | Welireg, Keytruda |
| Endo Pharmaceuticals INC. | $85.26 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $80.64 | 2022-2023 | Pylarify |
| Axogen | $79.16 | 2025 | |
| Clarus Therapeutics INC. | $75.95 | 2021 | |
| Allergan, INC. | $70.16 | 2022 | |
| 180 Medical, INC. | $66.37 | 2021-2023 | Gentlecath |
| Millicent US INC | $54.41 | 2023-2024 | Intrarosa, Femring |
| Amgen INC. | $45.18 | 2021-2022 | |
| Convatec INC. | $37.30 | 2024 | |
| Olympus America INC. | $36.04 | 2022-2025 | Itind System |
| Verity Pharmaceuticals INC. | $29.99 | 2024 | Trelstar |
| Procept Biorobotics Corporation | $28.24 | 2024 | Aquabeam System |
| Inspire Medical Systems, INC. | $27.94 | 2025 | Inspire |
| Kowa Pharmaceuticals America, INC. | $24.53 | 2022 | |
| Calyxo, INC. | $23.57 | 2025 | Cvac Aspiration System |
| Lsi Solutions INC | $23.41 | 2024 | Jnw Urtrac, Running Device, Ti-Knot |
| Abc Home Medical Supply, INC. | $22.97 | 2024 | |
| Hollister Incorporated | $20.53 | 2022 | |
| Bioprotect Medical, INC. | $19.12 | 2025 | Bioprotect Balloon Implant System |
| Halozyme INC | $18.81 | 2023 | |
| Azurity Pharmaceuticals, INC. | $16.63 | 2025 | Azmiro |
| Photocure INC | $13.74 | 2025 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Jenney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.